Scientists Ask Elizabeth Arden to Protect Consumers and Animals
The Physicians Committee is asking cosmetic and fragrance company Elizabeth Arden Inc. shareholders to encourage the board to pass a resolution to protect consumers by increasing transparency around animals testing.
“By conducting animal testing, Arden fails to protect its consumers,” states the resolution drafted by Physicians Committee director of regulatory testing Kristie Sullivan, M.P.H., and Aryenish Birdie, regulatory testing policy coordinator. “When researchers took a retrospective look at 150 human clinical trials of inflammatory diseases (including asthma, commonly triggered by fragrances) they found 100 percent of drugs developed using mice failed. Another example from a peer-reviewed article found that adult women who were exposed to common scented products, including fragrances, had an increased risk of cardiovascular health hazards. Animals are not useful predictors of diseases or toxicity. The National Academy of Sciences agrees that many animal-based tests are not human-relevant.”
The resolution also points out that tests conducted on Arden’s behalf are likely extremely cruel: “Fragrances may be tested in nose-only inhalation tests, in which an experimenter shoves animals face-first into tubes no larger than their bodies, to force them to breathe the airborne test item. The animals are kept there for four to six hours, daily, for up to three months.”
The resolution requests that Arden make information on its animal use publicly available on its website and accessible on a constant basis, updated annually.
Physicians Committee members who own Arden stock should submit their vote in favor of the Physicians Committee’s resolution and encourage family and friends who own Arden stock to do the same. Questions about the resolution, which will be voted on in November, should be submitted to email@example.com.
To learn more about the Physicians Committee’s international cosmetics regulation reform efforts, visit PCRM.org/Cosmetics.